Join Growin Stock Community!

寶利徠1813.TW Overview

TW StockBiotech. & Medical
(No presentation for 1813)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

寶利徠（1813）Overall Performance

寶利徠（1813）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

寶利徠（1813） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

寶利徠（1813）Key Information

寶利徠（1813）Profile

Polylite Taiwan Co., Ltd. processes, manufactures, imports and exports, and sells various lenses, optical instruments, and medical equipment worldwide. Its GIA polycarbonate lenses, including FSV, SFSV, progressive, KID, and polarized lenses. The company was founded in 1982 and is based in Taoyuan, Taiwan.

寶利徠（1813）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.52
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
2.03
PB Ratio
0.93
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-22.00%
Net Margin
-23.06%
Revenue Growth (YoY)
-7.44%
Profit Growth (YoY)
-209.42%
3-Year Revenue Growth
-11.13%
3-Year Profit Growth
38.29%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.52
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
2.03
PB Ratio
0.93
Price-to-FCF
-
Gross Margin
-22.00%
Net Margin
-23.06%
Revenue Growth (YoY)
-7.44%
Profit Growth (YoY)
-209.42%
3-Year Revenue Growth
-11.13%
3-Year Profit Growth
38.29%
default symbol

1813

寶利徠

13.35D

0.00%

(0.00)

  • When is 1813's latest earnings report released?

    The most recent financial report for 寶利徠 (1813) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1813's short-term business performance and financial health. For the latest updates on 1813's earnings releases, visit this page regularly.

  • What is the operating profit of 1813?

    According to the latest financial report, 寶利徠 (1813) reported an Operating Profit of -33.82M with an Operating Margin of -48.39% this period, representing a decline of 3.13% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 1813's revenue growth?

    In the latest financial report, 寶利徠 (1813) announced revenue of 69.89M, with a Year-Over-Year growth rate of -9.26%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 1813 have?

    At the end of the period, 寶利徠 (1813) held Total Cash and Cash Equivalents of 160.06M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 1813 go with three margins increasing?

    In the latest report, 寶利徠 (1813) did not achieve the “three margins increasing” benchmark, with a gross margin of -22.12%%, operating margin of -48.39%%, and net margin of 8.41%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1813's profit trajectory and future growth potential.

  • Is 1813's EPS continuing to grow?

    According to the past four quarterly reports, 寶利徠 (1813)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.11. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 1813?

    寶利徠 (1813)'s Free Cash Flow (FCF) for the period is 26.41M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 16.58% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.